SCHEMBL3570481

SCHEMBL3570481

CCOC(=O)c1c(Cl)c2cc(B3OC(C)(C)C(C)(C)O3)ccc2n1-c1ccc(OC2CCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.39
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
HIF1A Q16665 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
THRB P10828 1/20 0.34
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
TP53 P04637 2/20 0.34
PTGS2 P35354 1/20 0.33
MAPT P10636 4/20 0.33
EPHX2 P34913 1/20 0.33
HTT P42858 3/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3579153 0.85 UCHL1 (0.41) UCHL1HIF1ASMN1; SMN2THRBTP53
SCHEMBL3577723 0.83 MAOA (0.39) MAOAMAOBSMN1; SMN2THRBSCN1A
SCHEMBL3567412 0.83 MAPT (0.42) MAOAMAOBSMN1; SMN2THRBSCN1A
SCHEMBL3571455 0.82 MAOA (0.41) UCHL1MAOAMAOBHIF1ASCN1A
SCHEMBL3575302 0.81 THRB (0.39) MAOAMAOBSMN1; SMN2THRBTP53
SCHEMBL4922812 0.78 THRB (0.41) MAOAMAOBSMN1; SMN2THRBTP53
SCHEMBL4918631 0.78 EPHX2 (0.47) EPHX2
SCHEMBL3573660 0.76 FAAH (0.40) MAOAMAOBPTGS2MAPTMAPK1
SCHEMBL3005796 0.76 UCHL1 (0.40) UCHL1HIF1ASMN1; SMN2THRBTP53
SCHEMBL3013557 0.75 UCHL1 (0.39) UCHL1HIF1ASMN1; SMN2THRBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705023-B2 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2010-04-27 US disclosed
EP-1778632-B1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2008-08-20 EP disclosed
US-20070287715-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2007-12-13 US disclosed
EP-1778632-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-05-02 EP disclosed
WO-2005123673-A1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287715-A1 Indoles Useful in the Treatment of Inflammation PTGS1, IDO1, PTGES UCHL1 1933/4885MAOA 153/4885MAOB 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.